课题基金 / 基金详情

Collaborative Research: Center for Pharmaceutical Manufacturing and Formulation

Collaborative Research: Center for Pharmaceutical Manufacturing and Formulation
合作研究:药品制造和制剂中心
批准号:
0832469
负责人:
Andreas Bommarius
金额:
$1.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-15 至 2010-07-31

项目摘要

项目成果

Andreas Bommarius的其他基金

相似基金

相关文献

中文摘要
翻译
0832469佐治亚理工学院;安德烈亚斯·博马里斯0832530堪萨斯大学;埃里克·芒森0832478杜肯大学;詹姆斯·德伦南佐治亚理工学院、堪萨斯大学和杜肯大学提议为合作中心“制药制造和配方中心(CPMF)”提供规划赠款,以应对制药行业当前的挑战,目的是开发解决方案,以实现更具选择性和健壮的制造工艺、更稳定的配方、更具特性和一致性的产品。该中心将为来自政府、学术界和工业界的科学家之间的合作项目提供一个机制,以开发创新的方法,以更少的环境足迹实现更具选择性和更强大的过程,并提高国家药品供应的安全性。拟议的研究议程包括制造、配方和分析。制造的重点是从目前的间歇过程规范过渡到微规模和连续过程。将假药和降级药品的检测和快速鉴定方法的制造、配方和分析相结合,将促进该领域知识的进步。这些领域的进步将有助于降低生产成本,并有助于维持这些公司的生存。拟议的工作将提高开发安全药物和药物配方的能力。与制药业的合作将促进技术和信息的快速传播和应用,从而增加价值。拟议的中心(CPMF)将促进参与研究的学生进行学习。CPMF还将重点招聘研究生教育中代表性不足的群体,包括演讲和访问为代表性不足群体服务的学院和大学,特别是在教职员工是校友的学院和大学。
英文摘要
Planning Grant for an I/UCRC for Pharmaceutical Manufacturing and Formulation 0832469 Georgia Tech; Andreas Bommarius 0832530 University of Kansas; Eric Munson 0832478 Duquesne University; James Drennen Georgia Institute of Technology, University of Kansas, and Duquesne University propose a planning grant for a collaborative center "Center for Pharmaceutical Manufacturing and Formulation (CPMF)" to address current challenges in the pharmaceutical industry with the aim of developing solutions towards more selective and robust manufacturing processes, more stable formulations, and better characterized and consistent products. The Center will provide a mechanism for collaborative projects between scientists from government, academia, and industry to develop innovative methods towards more selective and robust processes with less environmental footprint and to improve the safety of the nations drug supply. The proposed research agenda includes manufacturing, formulation, and analytical. The manufacturing focus is on transitioning to microscale and continuous process from the current norm of batch processes. The integration of manufacturing, formulation, and analyses of the approaches to testing and rapid identification of counterfeit and degraded drugs will lead to an advancement in knowledge in the field. Advances in these areas would help mitigate production costs, and would help keep the companies viable. The proposed work will improve the ability to develop safe drugs and drug formulations. Collaborations with the pharmaceutical industry will add value by promoting the rapid dissemination and application of technologies and information. The proposed center (CPMF) will promote learning by participant students as they conduct their research. CPMF will also place emphasis on recruiting under-represented groups in the graduate education, including presentations and visits to colleges and universities that serve under-represented groups, especially where the faculty are alumni.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I/UCRC Phase II: Collaborative Research: Center for Pharmaceutical Development (CPD)
  • 批准号:
    1540017
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $48.53万
  • 财政年份:
    2015
  • 负责人:
    Andreas Bommarius
  • 依托单位:
UNS:New protein function: developing a family of amine dehydrogenases
  • 批准号:
    1512848
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $40.75万
  • 财政年份:
    2015
  • 负责人:
    Andreas Bommarius
  • 依托单位:
Center for Pharmaceutical Development
  • 批准号:
    0969003
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $40.0万
  • 财政年份:
    2010
  • 负责人:
    Andreas Bommarius
  • 依托单位:
国内基金
海外基金
Research on Quantum Field Theory without a Lagrangian Description
  • 批准号:
    24ZR1403900
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    SATOSHI NAWATA
  • 依托单位:
Cell Research
Cell Research
Cell Research (细胞研究)